Unternehmen Intercept Pharmaceuticals, Inc.
Aktien
A1J5U0
US45845P1084
ICPT
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 341
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23.02.17 |
Andrew Saik
DFI | Director of Finance/CFO | 54 | 21.06.21 |
M. Berrey
CTO | Chief Tech/Sci/R&D Officer | 57 | 09.06.21 |
Jose Truzman
SEC | Corporate Secretary | - | - |
Rocco Venezia
AUD | Comptroller/Controller/Auditor | 48 | 01.01.16 |
General Counsel | 55 | 11.01.21 | |
Corporate Officer/Principal | 60 | 01.01.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23.02.17 |
Director/Board Member | 55 | 08.11. | |
Stefano Pasi
BRD | Director/Board Member | - | 08.11. |
Michele Cera
BRD | Director/Board Member | - | 08.11. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 41 825 966 | 40 940 614 ( 97,88 %) | 0 | 97,88 % |
Unternehmenskontakt
Intercept Pharmaceuticals, Inc.
305 Madison Avenue
07960, Morristown
+646 747 1000
http://www.interceptpharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
-3.46% | 102 Mrd. | |
+1.41% | 96.09 Mrd. | |
+2.13% | 22.28 Mrd. | |
-15.84% | 21.4 Mrd. | |
-9.21% | 18.14 Mrd. | |
-39.98% | 17.02 Mrd. | |
-14.65% | 16.09 Mrd. | |
+4.39% | 13.83 Mrd. | |
+31.35% | 11.97 Mrd. |